Global Clinical Oncology Next Generation Sequencing Market Size, Share - Forecast 2034
Clinical Oncology Next Generation Sequencing Market By Component (Sequencing Platforms, Sequencing Products, Kits And Reagents, Services), By Technology (Ion Semiconductor Sequencing, Pyro-Sequencing, Synthesis Sequencing (Sbs), Real Time Sequencing (Smrt), Ligation Sequencing, Reversible Dye Termination Sequencing, Nano-Pore Sequencing), By Application (Whole Tumor Genome Sequencing, Whole Tumor Exome Sequencing, Targeted Tumor Genome Profiling, Tumor Transcriptome Sequencing, Tumor-Normal Comparisons, Others), By End User (Hospitals, Laboratories, Clinical Research Organizations, Diagnostic Laboratories, Others), and By Region: Global and Regional Industry Overview, Market Intelligence, Comprehensive Analysis, Historical Data, and Forecasts 2025 - 2034
Category: Biotechnology Report Format : PDF
Pages: 203 Report Code: ZMR-4906
Published Date: Jun-2025 Status : Published
| Market Size in 2024 | Market Forecast in 2034 | CAGR (in %) | Base Year |
|---|---|---|---|
| USD 635.74 Million | USD 3135.16 Million | 17.3% | 2024 |
Table Of Content
- Chapter 1. Preface
- 1.1 Report Description and Scope
- 1.2 Research scope
- 1.3 Research methodology
- 1.3.1 Market Research Type
- 1.3.2 Market research methodology
- Chapter 2. Executive Summary
- 2.1 Global Clinical Oncology Next Generation Sequencing Market, (2023 - 2030) (USD Million)
- 2.2 Global Clinical Oncology Next Generation Sequencing Market : snapshot
- Chapter 3. Global Clinical Oncology Next Generation Sequencing Market - Industry Analysis
- 3.1 Clinical Oncology Next Generation Sequencing Market: Market Dynamics
- 3.2 Market Drivers
- 3.2.1 Surge in healthcare spending will steer the global market surge over the forecast period
- 3.3 Market Restraints
- 3.3.1. Massive costs related to NGS systems can put brakes on the global industry expansion by 2030
- 3.4 Market Opportunities
- 3.4.1. Reduced prices of NGS systems can help market explore new domains of growth globally
- 3.5 Market Challenges
- 3.5.1. Escalating costs of deploying NGS tools can prove to be a huge challenge for the global industry
- 3.6 Porter’s Five Forces Analysis
- 3.7 Market Attractiveness Analysis
- 3.7.1 Market attractiveness analysis By Technology
- 3.7.2 Market attractiveness analysis By Workflow
- 3.7.3 Market attractiveness analysis By Application
- 3.7.4 Market attractiveness analysis By End-User
- Chapter 4. Global Clinical Oncology Next Generation Sequencing Market- Competitive Landscape
- 4.1 Company market share analysis
- 4.1.1 Global Clinical Oncology Next Generation Sequencing Market: company market share, 2022
- 4.2 Strategic development
- 4.2.1 Acquisitions & mergers
- 4.2.2 New Product launches
- 4.2.3 Agreements, partnerships, cullaborations, and joint ventures
- 4.2.4 Research and development and Regional expansion
- 4.3 Price trend analysis
- 4.1 Company market share analysis
- Chapter 5. Global Clinical Oncology Next Generation Sequencing Market - Technology Analysis
- 5.1 Global Clinical Oncology Next Generation Sequencing Market overview: By Technology
- 5.1.1 Global Clinical Oncology Next Generation Sequencing Market share, By Technology, 2022 and 2030
- 5.2 Whole Genome Sequencing
- 5.2.1 Global Clinical Oncology Next Generation Sequencing Market by Whole Genome Sequencing, 2023 - 2030 (USD Million)
- 5.3 Whole Exome Sequencing
- 5.3.1 Global Clinical Oncology Next Generation Sequencing Market by Whole Exome Sequencing, 2023 - 2030 (USD Million)
- 5.4 Targeted Sequencing & Re-Sequencing
- 5.4.1 Global Clinical Oncology Next Generation Sequencing Market by Targeted Sequencing & Re-Sequencing, 2023 - 2030 (USD Million)
- 5.1 Global Clinical Oncology Next Generation Sequencing Market overview: By Technology
- Chapter 6. Global Clinical Oncology Next Generation Sequencing Market - Workflow Analysis
- 6.1 Global Clinical Oncology Next Generation Sequencing Market overview: By Workflow
- 6.1.1 Global Clinical Oncology Next Generation Sequencing Market share, By Workflow, 2022 and 2030
- 6.2 NGS Pre-Sequencing
- 6.2.1 Global Clinical Oncology Next Generation Sequencing Market by NGS Pre-Sequencing, 2023 - 2030 (USD Million)
- 6.3 NGS Sequencing
- 6.3.1 Global Clinical Oncology Next Generation Sequencing Market by NGS Sequencing, 2023 - 2030 (USD Million)
- 6.4 NGS Data Analysis
- 6.4.1 Global Clinical Oncology Next Generation Sequencing Market by NGS Data Analysis, 2023 - 2030 (USD Million)
- 6.1 Global Clinical Oncology Next Generation Sequencing Market overview: By Workflow
- Chapter 7. Global Clinical Oncology Next Generation Sequencing Market - Application Analysis
- 7.1 Global Clinical Oncology Next Generation Sequencing Market overview: By Application
- 7.1.1 Global Clinical Oncology Next Generation Sequencing Market share, By Application, 2022 and 2030
- 7.2 Screening
- 7.2.1 Global Clinical Oncology Next Generation Sequencing Market by Screening, 2023 - 2030 (USD Million)
- 7.3 Companion Diagnostics
- 7.3.1 Global Clinical Oncology Next Generation Sequencing Market by Companion Diagnostics, 2023 - 2030 (USD Million)
- 7.4 Others
- 7.4.1 Global Clinical Oncology Next Generation Sequencing Market by Others, 2023 - 2030 (USD Million)
- 7.1 Global Clinical Oncology Next Generation Sequencing Market overview: By Application
- Chapter 8. Global Clinical Oncology Next Generation Sequencing Market - End-User Analysis
- 8.1 Global Clinical Oncology Next Generation Sequencing Market overview: By End-User
- 8.1.1 Global Clinical Oncology Next Generation Sequencing Market share, By End-User, 2022 and 2030
- 8.2 Hospitals
- 8.2.1 Global Clinical Oncology Next Generation Sequencing Market by Hospitals, 2023 - 2030 (USD Million)
- 8.3 Clinics
- 8.3.1 Global Clinical Oncology Next Generation Sequencing Market by Clinics, 2023 - 2030 (USD Million)
- 8.4 Laboratories
- 8.4.1 Global Clinical Oncology Next Generation Sequencing Market by Laboratories, 2023 - 2030 (USD Million)
- 8.5 Others
- 8.5.1 Global Clinical Oncology Next Generation Sequencing Market by Others, 2023 - 2030 (USD Million)
- 8.1 Global Clinical Oncology Next Generation Sequencing Market overview: By End-User
- Chapter 9. Clinical Oncology Next Generation Sequencing Market - Regional Analysis
- 9.1 Global Clinical Oncology Next Generation Sequencing Market Regional Overview
- 9.2 Global Clinical Oncology Next Generation Sequencing Market Share, by Region, 2022 & 2030 (USD Million)
- 9.3. North America
- 9.3.1 North America Clinical Oncology Next Generation Sequencing Market, 2023 - 2030 (USD Million)
- 9.3.1.1 North America Clinical Oncology Next Generation Sequencing Market, by Country, 2023 - 2030 (USD Million)
- 9.3.1 North America Clinical Oncology Next Generation Sequencing Market, 2023 - 2030 (USD Million)
- 9.4 North America Clinical Oncology Next Generation Sequencing Market, by Technology, 2023 - 2030
- 9.4.1 North America Clinical Oncology Next Generation Sequencing Market, by Technology, 2023 - 2030 (USD Million)
- 9.5 North America Clinical Oncology Next Generation Sequencing Market, by Workflow, 2023 - 2030
- 9.5.1 North America Clinical Oncology Next Generation Sequencing Market, by Workflow, 2023 - 2030 (USD Million)
- 9.6 North America Clinical Oncology Next Generation Sequencing Market, by Application, 2023 - 2030
- 9.6.1 North America Clinical Oncology Next Generation Sequencing Market, by Application, 2023 - 2030 (USD Million)
- 9.7 North America Clinical Oncology Next Generation Sequencing Market, by End-User, 2023 - 2030
- 9.7.1 North America Clinical Oncology Next Generation Sequencing Market, by End-User, 2023 - 2030 (USD Million)
- 9.4. Europe
- 9.4.2 Europe Clinical Oncology Next Generation Sequencing Market, 2023 - 2030 (USD Million)
- 9.4.2.1 Europe Clinical Oncology Next Generation Sequencing Market, by Country, 2023 - 2030 (USD Million)
- 9.4.2 Europe Clinical Oncology Next Generation Sequencing Market, 2023 - 2030 (USD Million)
- 9.4 Europe Clinical Oncology Next Generation Sequencing Market, by Technology, 2023 - 2030
- 9.4.1 Europe Clinical Oncology Next Generation Sequencing Market, by Technology, 2023 - 2030 (USD Million)
- 9.5 Europe Clinical Oncology Next Generation Sequencing Market, by Workflow, 2023 - 2030
- 9.5.1 Europe Clinical Oncology Next Generation Sequencing Market, by Workflow, 2023 - 2030 (USD Million)
- 9.6 Europe Clinical Oncology Next Generation Sequencing Market, by Application, 2023 - 2030
- 9.6.1 Europe Clinical Oncology Next Generation Sequencing Market, by Application, 2023 - 2030 (USD Million)
- 9.7 Europe Clinical Oncology Next Generation Sequencing Market, by End-User, 2023 - 2030
- 9.7.1 Europe Clinical Oncology Next Generation Sequencing Market, by End-User, 2023 - 2030 (USD Million)
- 9.5. Asia Pacific
- 9.5.3 Asia Pacific Clinical Oncology Next Generation Sequencing Market, 2023 - 2030 (USD Million)
- 9.5.3.1 Asia Pacific Clinical Oncology Next Generation Sequencing Market, by Country, 2023 - 2030 (USD Million)
- 9.5.3 Asia Pacific Clinical Oncology Next Generation Sequencing Market, 2023 - 2030 (USD Million)
- 9.4 Asia Pacific Clinical Oncology Next Generation Sequencing Market, by Technology, 2023 - 2030
- 9.4.1 Asia Pacific Clinical Oncology Next Generation Sequencing Market, by Technology, 2023 - 2030 (USD Million)
- 9.5 Asia Pacific Clinical Oncology Next Generation Sequencing Market, by Workflow, 2023 - 2030
- 9.5.1 Asia Pacific Clinical Oncology Next Generation Sequencing Market, by Workflow, 2023 - 2030 (USD Million)
- 9.6 Asia Pacific Clinical Oncology Next Generation Sequencing Market, by Application, 2023 - 2030
- 9.6.1 Asia Pacific Clinical Oncology Next Generation Sequencing Market, by Application, 2023 - 2030 (USD Million)
- 9.7 Asia Pacific Clinical Oncology Next Generation Sequencing Market, by End-User, 2023 - 2030
- 9.7.1 Asia Pacific Clinical Oncology Next Generation Sequencing Market, by End-User, 2023 - 2030 (USD Million)
- 9.6. Latin America
- 9.6.4 Latin America Clinical Oncology Next Generation Sequencing Market, 2023 - 2030 (USD Million)
- 9.6.4.1 Latin America Clinical Oncology Next Generation Sequencing Market, by Country, 2023 - 2030 (USD Million)
- 9.6.4 Latin America Clinical Oncology Next Generation Sequencing Market, 2023 - 2030 (USD Million)
- 9.4 Latin America Clinical Oncology Next Generation Sequencing Market, by Technology, 2023 - 2030
- 9.4.1 Latin America Clinical Oncology Next Generation Sequencing Market, by Technology, 2023 - 2030 (USD Million)
- 9.5 Latin America Clinical Oncology Next Generation Sequencing Market, by Workflow, 2023 - 2030
- 9.5.1 Latin America Clinical Oncology Next Generation Sequencing Market, by Workflow, 2023 - 2030 (USD Million)
- 9.6 Latin America Clinical Oncology Next Generation Sequencing Market, by Application, 2023 - 2030
- 9.6.1 Latin America Clinical Oncology Next Generation Sequencing Market, by Application, 2023 - 2030 (USD Million)
- 9.7 Latin America Clinical Oncology Next Generation Sequencing Market, by End-User, 2023 - 2030
- 9.7.1 Latin America Clinical Oncology Next Generation Sequencing Market, by End-User, 2023 - 2030 (USD Million)
- 9.7. The Middle-East and Africa
- 9.7.5 The Middle-East and Africa Clinical Oncology Next Generation Sequencing Market, 2023 - 2030 (USD Million)
- 9.7.5.1 The Middle-East and Africa Clinical Oncology Next Generation Sequencing Market, by Country, 2023 - 2030 (USD Million)
- 9.7.5 The Middle-East and Africa Clinical Oncology Next Generation Sequencing Market, 2023 - 2030 (USD Million)
- 9.4 The Middle-East and Africa Clinical Oncology Next Generation Sequencing Market, by Technology, 2023 - 2030
- 9.4.1 The Middle-East and Africa Clinical Oncology Next Generation Sequencing Market, by Technology, 2023 - 2030 (USD Million)
- 9.5 The Middle-East and Africa Clinical Oncology Next Generation Sequencing Market, by Workflow, 2023 - 2030
- 9.5.1 The Middle-East and Africa Clinical Oncology Next Generation Sequencing Market, by Workflow, 2023 - 2030 (USD Million)
- 9.6 The Middle-East and Africa Clinical Oncology Next Generation Sequencing Market, by Application, 2023 - 2030
- 9.6.1 The Middle-East and Africa Clinical Oncology Next Generation Sequencing Market, by Application, 2023 - 2030 (USD Million)
- 9.7 The Middle-East and Africa Clinical Oncology Next Generation Sequencing Market, by End-User, 2023 - 2030
- 9.7.1 The Middle-East and Africa Clinical Oncology Next Generation Sequencing Market, by End-User, 2023 - 2030 (USD Million)
- Chapter 10. Company Profiles
- 10.1 Agilent
- 10.1.1 Overview
- 10.1.2 Financials
- 10.1.3 Product Portfolio
- 10.1.4 Business Strategy
- 10.1.5 Recent Developments
- 10.2 Beijing Genomics Institute (BGI)
- 10.2.1 Overview
- 10.2.2 Financials
- 10.2.3 Product Portfolio
- 10.2.4 Business Strategy
- 10.2.5 Recent Developments
- 10.3 Qiagen NV
- 10.3.1 Overview
- 10.3.2 Financials
- 10.3.3 Product Portfolio
- 10.3.4 Business Strategy
- 10.3.5 Recent Developments
- 10.4 Oxford Nanopore Technologies Ltd.
- 10.4.1 Overview
- 10.4.2 Financials
- 10.4.3 Product Portfolio
- 10.4.4 Business Strategy
- 10.4.5 Recent Developments
- 10.5 Caris Life Sciences
- 10.5.1 Overview
- 10.5.2 Financials
- 10.5.3 Product Portfolio
- 10.5.4 Business Strategy
- 10.5.5 Recent Developments
- 10.6 Eurofins Scientific
- 10.6.1 Overview
- 10.6.2 Financials
- 10.6.3 Product Portfolio
- 10.6.4 Business Strategy
- 10.6.5 Recent Developments
- 10.7 Perkin Elmer Inc.
- 10.7.1 Overview
- 10.7.2 Financials
- 10.7.3 Product Portfolio
- 10.7.4 Business Strategy
- 10.7.5 Recent Developments
- 10.8 Foundation Medicine
- 10.8.1 Overview
- 10.8.2 Financials
- 10.8.3 Product Portfolio
- 10.8.4 Business Strategy
- 10.8.5 Recent Developments
- 10.9 Myriad Genetics
- 10.9.1 Overview
- 10.9.2 Financials
- 10.9.3 Product Portfolio
- 10.9.4 Business Strategy
- 10.9.5 Recent Developments
- 10.10 Partek Inc.
- 10.10.1 Overview
- 10.10.2 Financials
- 10.10.3 Product Portfolio
- 10.10.4 Business Strategy
- 10.10.5 Recent Developments
- 10.11 Pacific Bioscience Inc.
- 10.11.1 Overview
- 10.11.2 Financials
- 10.11.3 Product Portfolio
- 10.11.4 Business Strategy
- 10.11.5 Recent Developments
- 10.12 Paradigm Diagnostics Inc.
- 10.12.1 Overview
- 10.12.2 Financials
- 10.12.3 Product Portfolio
- 10.12.4 Business Strategy
- 10.12.5 Recent Developments
- 10.13 Thermo Fisher Scientific Corporation
- 10.13.1 Overview
- 10.13.2 Financials
- 10.13.3 Product Portfolio
- 10.13.4 Business Strategy
- 10.13.5 Recent Developments
- 10.14 and others.
- 10.14.1 Overview
- 10.14.2 Financials
- 10.14.3 Product Portfolio
- 10.14.4 Business Strategy
- 10.14.5 Recent Developments
- 10.1 Agilent
Table Of Figures
- 1. Market research Type
- 2. Market research methodology
- 3. Global Clinical Oncology Next Generation Sequencing Market, 2023 - 2030 (USD Million)
- 4. Porter’s Five Forces Analysis
- 5. Global Clinical Oncology Next Generation Sequencing Market attractiveness, By Technology
- 6. Global Clinical Oncology Next Generation Sequencing Market attractiveness, By Workflow
- 7. Global Clinical Oncology Next Generation Sequencing Market attractiveness, By Application
- 8. Global Clinical Oncology Next Generation Sequencing Market attractiveness, By End-User
- 9. Global Clinical Oncology Next Generation Sequencing Market share by Technology, 2023 and 2030 (USD Million)
- 10. Global Clinical Oncology Next Generation Sequencing Market by Whole Genome Sequencing, 2023 - 2030 (USD Million)
- 11. Global Clinical Oncology Next Generation Sequencing Market by Whole Exome Sequencing, 2023 - 2030 (USD Million)
- 12. Global Clinical Oncology Next Generation Sequencing Market by Targeted Sequencing & Re-Sequencing, 2023 - 2030 (USD Million)
- 13. Global Clinical Oncology Next Generation Sequencing Market share by Workflow, 2023 and 2030 (USD Million)
- 14. Global Clinical Oncology Next Generation Sequencing Market by NGS Pre-Sequencing, 2023 - 2030 (USD Million)
- 15. Global Clinical Oncology Next Generation Sequencing Market by NGS Sequencing, 2023 - 2030 (USD Million)
- 16. Global Clinical Oncology Next Generation Sequencing Market by NGS Data Analysis, 2023 - 2030 (USD Million)
- 17. Global Clinical Oncology Next Generation Sequencing Market share by Application, 2023 and 2030 (USD Million)
- 18. Global Clinical Oncology Next Generation Sequencing Market by Screening, 2023 - 2030 (USD Million)
- 19. Global Clinical Oncology Next Generation Sequencing Market by Companion Diagnostics, 2023 - 2030 (USD Million)
- 20. Global Clinical Oncology Next Generation Sequencing Market by Others, 2023 - 2030 (USD Million)
- 21. Global Clinical Oncology Next Generation Sequencing Market share by End-User, 2023 and 2030 (USD Million)
- 22. Global Clinical Oncology Next Generation Sequencing Market by Hospitals, 2023 - 2030 (USD Million)
- 23. Global Clinical Oncology Next Generation Sequencing Market by Clinics, 2023 - 2030 (USD Million)
- 24. Global Clinical Oncology Next Generation Sequencing Market by Laboratories, 2023 - 2030 (USD Million)
- 25. Global Clinical Oncology Next Generation Sequencing Market by Others, 2023 - 2030 (USD Million)
- 26. Global Clinical Oncology Next Generation Sequencing Market share, by Region, 2023 and 2030
- 27. North America Clinical Oncology Next Generation Sequencing Market, 2023 - 2030 (USD Million)
- 28. Europe Clinical Oncology Next Generation Sequencing Market, 2023 - 2030 (USD Million)
- 29. Asia Pacific Clinical Oncology Next Generation Sequencing Market, 2023 - 2030 (USD Million)
- 30. Latin America Clinical Oncology Next Generation Sequencing Market, 2023 - 2030 (USD Million)
- 31. The Middle-East and Africa Clinical Oncology Next Generation Sequencing Market, 2023 - 2030 (USD Million)
Table Of Tables
- 1. Global Clinical Oncology Next Generation Sequencing Market: Snapshot
- 2. Drivers of the Clinical Oncology Next Generation Sequencing Market: impact analysis
- 3. North America Clinical Oncology Next Generation Sequencing Market revenue, By Technology, 2023 - 2030 (USD Million)
- 4. North America Clinical Oncology Next Generation Sequencing Market revenue, By Workflow, 2023 - 2030 (USD Million)
- 5. North America Clinical Oncology Next Generation Sequencing Market revenue, By Application, 2023 - 2030 (USD Million)
- 6. North America Clinical Oncology Next Generation Sequencing Market revenue, By End-User, 2023 - 2030 (USD Million)
- 7. U.S. Clinical Oncology Next Generation Sequencing Market revenue, By Technology, 2023 - 2030 (USD Million)
- 8. U.S. Clinical Oncology Next Generation Sequencing Market revenue, By Workflow, 2023 - 2030 (USD Million)
- 9. U.S. Clinical Oncology Next Generation Sequencing Market revenue, By Application, 2023 - 2030 (USD Million)
- 10. U.S. Clinical Oncology Next Generation Sequencing Market revenue, By End-User, 2023 - 2030 (USD Million)
- 11. Canada Clinical Oncology Next Generation Sequencing Market revenue, By Technology, 2023 - 2030 (USD Million)
- 12. Canada Clinical Oncology Next Generation Sequencing Market revenue, By Workflow, 2023 - 2030 (USD Million)
- 13. Canada Clinical Oncology Next Generation Sequencing Market revenue, By Application, 2023 - 2030 (USD Million)
- 14. Canada Clinical Oncology Next Generation Sequencing Market revenue, By End-User, 2023 - 2030 (USD Million)
- 15. Europe Clinical Oncology Next Generation Sequencing Market revenue, By Technology, 2023 - 2030 (USD Million)
- 16. Europe Clinical Oncology Next Generation Sequencing Market revenue, By Workflow, 2023 - 2030 (USD Million)
- 17. Europe Clinical Oncology Next Generation Sequencing Market revenue, By Application, 2023 - 2030 (USD Million)
- 18. Europe Clinical Oncology Next Generation Sequencing Market revenue, By End-User, 2023 - 2030 (USD Million)
- 19. Germany Clinical Oncology Next Generation Sequencing Market revenue, By Technology, 2023 - 2030 (USD Million)
- 20. Germany Clinical Oncology Next Generation Sequencing Market revenue, By Workflow, 2023 - 2030 (USD Million)
- 21. Germany Clinical Oncology Next Generation Sequencing Market revenue, By Application, 2023 - 2030 (USD Million)
- 22. Germany Clinical Oncology Next Generation Sequencing Market revenue, By End-User, 2023 - 2030 (USD Million)
- 23. France Clinical Oncology Next Generation Sequencing Market revenue, By Technology, 2023 - 2030 (USD Million)
- 24. France Clinical Oncology Next Generation Sequencing Market revenue, By Workflow, 2023 - 2030 (USD Million)
- 25. France Clinical Oncology Next Generation Sequencing Market revenue, By Application, 2023 - 2030 (USD Million)
- 26. France Clinical Oncology Next Generation Sequencing Market revenue, By End-User, 2023 - 2030 (USD Million)
- 27. U.K. Clinical Oncology Next Generation Sequencing Market revenue, By Technology, 2023 - 2030 (USD Million)
- 28. U.K. Clinical Oncology Next Generation Sequencing Market revenue, By Workflow, 2023 - 2030 (USD Million)
- 29. U.K. Clinical Oncology Next Generation Sequencing Market revenue, By Application, 2023 - 2030 (USD Million)
- 30. U.K. Clinical Oncology Next Generation Sequencing Market revenue, By End-User, 2023 - 2030 (USD Million)
- 31. Italy Clinical Oncology Next Generation Sequencing Market revenue, By Technology, 2023 - 2030 (USD Million)
- 32. Italy Clinical Oncology Next Generation Sequencing Market revenue, By Workflow, 2023 - 2030 (USD Million)
- 33. Italy Clinical Oncology Next Generation Sequencing Market revenue, By Application, 2023 - 2030 (USD Million)
- 34. Italy Clinical Oncology Next Generation Sequencing Market revenue, By End-User, 2023 - 2030 (USD Million)
- 35. Spain Clinical Oncology Next Generation Sequencing Market revenue, By Technology, 2023 - 2030 (USD Million)
- 36. Spain Clinical Oncology Next Generation Sequencing Market revenue, By Workflow, 2023 - 2030 (USD Million)
- 37. Spain Clinical Oncology Next Generation Sequencing Market revenue, By Application, 2023 - 2030 (USD Million)
- 38. Spain Clinical Oncology Next Generation Sequencing Market revenue, By End-User, 2023 - 2030 (USD Million)
- 39. Rest of Europe Clinical Oncology Next Generation Sequencing Market revenue, By Technology, 2023 - 2030 (USD Million)
- 40. Rest of Europe Clinical Oncology Next Generation Sequencing Market revenue, By Workflow, 2023 - 2030 (USD Million)
- 41. Rest of Europe Clinical Oncology Next Generation Sequencing Market revenue, By Application, 2023 - 2030 (USD Million)
- 42. Rest of Europe Clinical Oncology Next Generation Sequencing Market revenue, By End-User, 2023 - 2030 (USD Million)
- 43. Asia Pacific Clinical Oncology Next Generation Sequencing Market revenue, By Technology, 2023 - 2030 (USD Million)
- 44. Asia Pacific Clinical Oncology Next Generation Sequencing Market revenue, By Workflow, 2023 - 2030 (USD Million)
- 45. Asia Pacific Clinical Oncology Next Generation Sequencing Market revenue, By Application, 2023 - 2030 (USD Million)
- 46. Asia Pacific Clinical Oncology Next Generation Sequencing Market revenue, By End-User, 2023 - 2030 (USD Million)
- 47. China Clinical Oncology Next Generation Sequencing Market revenue, By Technology, 2023 - 2030 (USD Million)
- 48. China Clinical Oncology Next Generation Sequencing Market revenue, By Workflow, 2023 - 2030 (USD Million)
- 49. China Clinical Oncology Next Generation Sequencing Market revenue, By Application, 2023 - 2030 (USD Million)
- 50. China Clinical Oncology Next Generation Sequencing Market revenue, By End-User, 2023 - 2030 (USD Million)
- 51. Japan Clinical Oncology Next Generation Sequencing Market revenue, By Technology, 2023 - 2030 (USD Million)
- 52. Japan Clinical Oncology Next Generation Sequencing Market revenue, By Workflow, 2023 - 2030 (USD Million)
- 53. Japan Clinical Oncology Next Generation Sequencing Market revenue, By Application, 2023 - 2030 (USD Million)
- 54. Japan Clinical Oncology Next Generation Sequencing Market revenue, By End-User, 2023 - 2030 (USD Million)
- 55. India Clinical Oncology Next Generation Sequencing Market revenue, By Technology, 2023 - 2030 (USD Million)
- 56. India Clinical Oncology Next Generation Sequencing Market revenue, By Workflow, 2023 - 2030 (USD Million)
- 57. India Clinical Oncology Next Generation Sequencing Market revenue, By Application, 2023 - 2030 (USD Million)
- 58. India Clinical Oncology Next Generation Sequencing Market revenue, By End-User, 2023 - 2030 (USD Million)
- 59. South Korea Clinical Oncology Next Generation Sequencing Market revenue, By Technology, 2023 - 2030 (USD Million)
- 60. South Korea Clinical Oncology Next Generation Sequencing Market revenue, By Workflow, 2023 - 2030 (USD Million)
- 61. South Korea Clinical Oncology Next Generation Sequencing Market revenue, By Application, 2023 - 2030 (USD Million)
- 62. South Korea Clinical Oncology Next Generation Sequencing Market revenue, By End-User, 2023 - 2030 (USD Million)
- 63. South-East Asia Clinical Oncology Next Generation Sequencing Market revenue, By Technology, 2023 - 2030 (USD Million)
- 64. South-East Asia Clinical Oncology Next Generation Sequencing Market revenue, By Workflow, 2023 - 2030 (USD Million)
- 65. South-East Asia Clinical Oncology Next Generation Sequencing Market revenue, By Application, 2023 - 2030 (USD Million)
- 66. South-East Asia Clinical Oncology Next Generation Sequencing Market revenue, By End-User, 2023 - 2030 (USD Million)
- 67. Rest of Asia Pacific Clinical Oncology Next Generation Sequencing Market revenue, By Technology, 2023 - 2030 (USD Million)
- 68. Rest of Asia Pacific Clinical Oncology Next Generation Sequencing Market revenue, By Workflow, 2023 - 2030 (USD Million)
- 69. Rest of Asia Pacific Clinical Oncology Next Generation Sequencing Market revenue, By Application, 2023 - 2030 (USD Million)
- 70. Rest of Asia Pacific Clinical Oncology Next Generation Sequencing Market revenue, By End-User, 2023 - 2030 (USD Million)
- 71. Latin America Clinical Oncology Next Generation Sequencing Market revenue, By Technology, 2023 - 2030 (USD Million)
- 72. Latin America Clinical Oncology Next Generation Sequencing Market revenue, By Workflow, 2023 - 2030 (USD Million)
- 73. Latin America Clinical Oncology Next Generation Sequencing Market revenue, By Application, 2023 - 2030 (USD Million)
- 74. Latin America Clinical Oncology Next Generation Sequencing Market revenue, By End-User, 2023 - 2030 (USD Million)
- 75. Brazil Clinical Oncology Next Generation Sequencing Market revenue, By Technology, 2023 - 2030 (USD Million)
- 76. Brazil Clinical Oncology Next Generation Sequencing Market revenue, By Workflow, 2023 - 2030 (USD Million)
- 77. Brazil Clinical Oncology Next Generation Sequencing Market revenue, By Application, 2023 - 2030 (USD Million)
- 78. Brazil Clinical Oncology Next Generation Sequencing Market revenue, By End-User, 2023 - 2030 (USD Million)
- 79. Mexico Clinical Oncology Next Generation Sequencing Market revenue, By Technology, 2023 - 2030 (USD Million)
- 80. Mexico Clinical Oncology Next Generation Sequencing Market revenue, By Workflow, 2023 - 2030 (USD Million)
- 81. Mexico Clinical Oncology Next Generation Sequencing Market revenue, By Application, 2023 - 2030 (USD Million)
- 82. Mexico Clinical Oncology Next Generation Sequencing Market revenue, By End-User, 2023 - 2030 (USD Million)
- 83. Rest of Latin America Clinical Oncology Next Generation Sequencing Market revenue, By Technology, 2023 - 2030 (USD Million)
- 84. Rest of Latin America Clinical Oncology Next Generation Sequencing Market revenue, By Workflow, 2023 - 2030 (USD Million)
- 85. Rest of Latin America Clinical Oncology Next Generation Sequencing Market revenue, By Application, 2023 - 2030 (USD Million)
- 86. Rest of Latin America Clinical Oncology Next Generation Sequencing Market revenue, By End-User, 2023 - 2030 (USD Million)
- 87. The Middle-East and Africa Clinical Oncology Next Generation Sequencing Market revenue, By Technology, 2023 - 2030 (USD Million)
- 88. The Middle-East and Africa Clinical Oncology Next Generation Sequencing Market revenue, By Workflow, 2023 - 2030 (USD Million)
- 89. The Middle-East and Africa Clinical Oncology Next Generation Sequencing Market revenue, By Application, 2023 - 2030 (USD Million)
- 90. The Middle-East and Africa Clinical Oncology Next Generation Sequencing Market revenue, By End-User, 2023 - 2030 (USD Million)
- 91. GCC Countries Clinical Oncology Next Generation Sequencing Market revenue, By Technology, 2023 - 2030 (USD Million)
- 92. GCC Countries Clinical Oncology Next Generation Sequencing Market revenue, By Workflow, 2023 - 2030 (USD Million)
- 93. GCC Countries Clinical Oncology Next Generation Sequencing Market revenue, By Application, 2023 - 2030 (USD Million)
- 94. GCC Countries Clinical Oncology Next Generation Sequencing Market revenue, By End-User, 2023 - 2030 (USD Million)
- 95. South Africa Clinical Oncology Next Generation Sequencing Market revenue, By Technology, 2023 - 2030 (USD Million)
- 96. South Africa Clinical Oncology Next Generation Sequencing Market revenue, By Workflow, 2023 - 2030 (USD Million)
- 97. South Africa Clinical Oncology Next Generation Sequencing Market revenue, By Application, 2023 - 2030 (USD Million)
- 98. South Africa Clinical Oncology Next Generation Sequencing Market revenue, By End-User, 2023 - 2030 (USD Million)
- 99. Rest of Middle-East Africa Clinical Oncology Next Generation Sequencing Market revenue, By Technology, 2023 - 2030 (USD Million)
- 100. Rest of Middle-East Africa Clinical Oncology Next Generation Sequencing Market revenue, By Workflow, 2023 - 2030 (USD Million)
- 101. Rest of Middle-East Africa Clinical Oncology Next Generation Sequencing Market revenue, By Application, 2023 - 2030 (USD Million)
- 102. Rest of Middle-East Africa Clinical Oncology Next Generation Sequencing Market revenue, By End-User, 2023 - 2030 (USD Million)
Methodology
FrequentlyAsked Questions
The global clinical oncology next generation sequencing market is expected to grow due to rising cancer prevalence, demand for personalized medicine, advancements in genomic technologies, and increasing investments in precision oncology research.
According to a study, the global clinical oncology next generation sequencing market size was worth around USD 635.74 Million in 2024 and is expected to reach USD 3135.16 Million by 2034.
The global clinical oncology next generation sequencing market is expected to grow at a CAGR of 17.3% during the forecast period.
North America is expected to dominate the clinical oncology next generation sequencing market over the forecast period.
Leading players in the global clinical oncology next generation sequencing market include Illumina Inc., Thermo Fisher Scientific Inc., Qiagen N.V., F. Hoffmann-La Roche Ltd., Pacific Biosciences of California, Inc., Oxford Nanopore Technologies Ltd., Agilent Technologies, Inc., BGI Group, PerkinElmer, Inc., Bio-Rad Laboratories, Inc., among others.
The report explores crucial aspects of the clinical oncology next generation sequencing market, including a detailed discussion of existing growth factors and restraints, while also examining future growth opportunities and challenges that impact the market.
HappyClients
